Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506479 · ClinicalTrials.gov registry record · NA
Study in Parkinson's Disease of Exercise
A NA study of Parkinson Disease, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 3
- Study locations
NCT01506479: Completed NA study of Parkinson Disease, sponsored by University of Colorado, Denver.
NCT01506479 is a NA study of Parkinson Disease that has completed, run by University of Colorado, Denver. The registered enrollment target is 128 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01506479, a NA study of Parkinson Disease, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to learn more about the effects of exercise on patients who have been recently diagnosed with Parkinson's disease (PD). The investigators are going to test two levels of exercise (moderate to vigorous) against no exercise. The investigators think that exercise may reduce the symptoms the of PD, and the investigators hope to learn what level of exercise will offer the most benefit.
Primary Outcome
To test whether individuals with de novo Parkinson's disease (naïve to drug treatment) can achieve the randomly assigned levels of mean exercise intensity (60-65% average HRmax or 80-85% average HRmax) and adhere to the exercise protocol.
Conditions Studied
Interventions
- BEHAVIORAL Vigorous Exercise
- BEHAVIORAL Moderate Exercise
- BEHAVIORAL No Intervention
Study Locations (3)
Colorado
- University of Colorado Denver - Aurora
Illinois
- University of Illinois, Chicago - Chicago
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01506479 record still lists
NCT01506479 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 3 interventions - of which Vigorous Exercise is the first listed.
NCT01506479 reports a single indexed study location in Colorado, Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01506479 about?
NCT01506479 is a clinical study titled "Study in Parkinson's Disease of Exercise". The purpose of this study is to learn more about the effects of exercise on patients who have been recently diagnosed with Parkinson's disease (PD). The investigators are going to test two levels of exercise (moderate to vigorous) against no exercise. The investigators think that exercise may reduce...
What is the current status of trial NCT01506479?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2012-05. Estimated completion is 2016-11.
What conditions does trial NCT01506479 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT01506479?
The interventions under investigation include: Vigorous Exercise (BEHAVIORAL), Moderate Exercise (BEHAVIORAL), No Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01506479?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01506479 being conducted?
This trial has 3 study locations across Colorado, Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01506479's enrollment target sits among peer trials
128 65th of 297 higher than 233 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia